NeuDirection Limited

Innovative Drugs
in CNS disease

Advancing Treatment for Neurological Challenges

Our Mission

Targeting unexplored G protein-coupled receptors (GPCRs) in the brain with novel small-molecule, neuropeptide mimetics for the treatment of rare and neglected Central Nervous System (CNS) diseases……

Our Mission

New Drug Pipelines

Explore our innovative drug pipelines


Neu-001, a novel small molecule agonist targeting a groundbreaking GPCR in the visual cortex, offers new hope for amblyopia patients.


Neu-002, an innovative small molecule agonist targeting a key GPCR in the auditory cortex, presents a novel approach to treating tinnitus.


Neu-003, a promising small molecule antagonist targeting a pivotal GPCR in the neocortex, represents a new frontier in epilepsy treatment.